Publications by authors named "A Nademanee"

Claim this Profile
Y
Yttrium-90 anti-CD25 BEAM conditioning for autologous hematopoietic cell transplantation in Peripheral T-cell lymphoma.
Jasmine Zain, Ni-Chun Tsai, Joycelynne Palmer, Jennifer Simpson, Vikram Adhikarla, Auayporn P Nademanee

Blood Adv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma.
Matthew Mei, Joycelynne Palmer, Nicole Ni-Chun Tsai, Jennifer Simpson, James O'Hearn, Auayporn Nademanee

Clin Lymphoma Myeloma Leuk· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial.
Alex F Herrera, Lu Chen, Yago Nieto, Leona Holmberg, Patrick Johnston, Auayporn Nademanee

Lancet Haematol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE.
Matthew G Mei, Hun Ju Lee, Joycelynne M Palmer, Robert Chen, Ni-Chun Tsai, Auayporn Nademanee

Blood· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma.
Alex F Herrera, Joycelynne Palmer, Vikram Adhikarla, Dave Yamauchi, Erasmus K Poku, Auayporn Nademanee

Blood Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis